✦ LIBER ✦

A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease

✍ Scribed by Abdullah Kutlar; Kenneth Ataga; Marvin Reid; Elliott P. Vichinsky; Lynne Neumayr; Loray Blair-Britt; Richard Labotka; Jonathan Glass; Jeffrey R. Keefer; William A. Wargin; Ronald Berenson; Susan P. Perrine

Book ID: 115549262
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 204 KB
Volume: 87
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23306

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, placebo-controlled phase

A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease

✍ Reid, Marvin E.; El Beshlawy, Amal; Inati, Adlette; Kutlar, Abdullah; Abboud, Mi 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

A phase 1/2A Trial of STA 5326, an oral

A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease

✍ Robert Burakoff; Charles F. Barish; Dennis Riff; Ronald Pruitt; William Y. Chey; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB